Cargando…

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma

Excision repair cross-complementing group 1 (ERCC1) functions as a nucleotide excision repair (NER) enzyme. Altered ERCC1 expression or function is closely associated with cancer development and progression. This study determined the association of ERCC1 expression with survivin expression, clinicop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Haiying, Yao, Shaobo, Dong, Qingyu, Zhang, Yanxia, Gong, Weihong, Jia, Zhongyao, Yan, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081142/ https://www.ncbi.nlm.nih.gov/pubmed/30075571 http://dx.doi.org/10.1097/MD.0000000000011697

Ejemplares similares

Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma: Erratum
Publicado: (2018)

Cell cycle association and hypoxia regulation of excision repair cross complementation group 1 protein (ERCC1) in tumor cells of head and neck cancer
por: Dudás, József, et al.
Publicado: (2014)

Overexpression of ubiquitin specific peptidase 14 predicts unfavorable prognosis in esophageal squamous cell carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2017)

Excision Repair Cross-Complementation Group 1 (ERCC1) Status and Lung Cancer Outcomes: A Meta-Analysis of Published Studies and Recommendations
por: Hubner, Richard A., et al.
Publicado: (2011)

ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells
por: Huang, Yi-Jung, et al.
Publicado: (2022)

Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin
por: Rao, Devika, et al.
Publicado: (2019)

Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer
por: Matsubara, J, et al.
Publicado: (2008)

PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma
por: Wang, Qiao, et al.
Publicado: (2018)

Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer
por: Joo, Jungnam, et al.
Publicado: (2016)

The Prognostic Value of Excision Repair Cross-Complementation Group 1 (ERCC1) in Patients with Small Cell Lung Cancer (SCLC) Receiving Platinum-Based Chemotherapy: Evidence from Meta-Analysis
por: Yang, Yanlong, et al.
Publicado: (2014)

Disruption of DNA repair in cancer cells by ubiquitination of a destabilising dimerization domain of nucleotide excision repair protein ERCC1
por: Yang, Lanlan, et al.
Publicado: (2017)

Association between XRCC1 and ERCC1 single-nucleotide polymorphisms and the efficacy of concurrent radiochemotherapy in patients with esophageal squamous cell carcinoma
por: Huang, Xue, et al.
Publicado: (2017)

XPF-ERCC1 protects liver, kidney and blood homeostasis outside the canonical excision repair pathways
por: Mulderrig, Lee, et al.
Publicado: (2020)

The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer
por: Sreekumar, Rahul, et al.
Publicado: (2021)

IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma
por: Maržić, Diana, et al.
Publicado: (2021)

Polymorphisms in the ERCC5 Gene and Risk of Esophageal Squamous Cell Carcinoma (ESCC) in Eastern Chinese Populations
por: Zhu, Mei-Ling, et al.
Publicado: (2012)

Potentially functional polymorphisms in the ERCC2 gene and risk of Esophageal Squamous Cell Carcinoma in Chinese populations
por: Zhu, Mei-Ling, et al.
Publicado: (2014)

The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
por: Jiang, Dongxian, et al.
Publicado: (2015)

Skp2 expression unfavorably impacts survival in resectable esophageal squamous cell carcinoma
por: Liang, Yi, et al.
Publicado: (2012)

Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma
por: Shi, Xuejiao, et al.
Publicado: (2016)

Overexpression of OLC1 Promotes Tumorigenesis of Human Esophageal Squamous Cell Carcinoma
por: Li, Xiao, et al.
Publicado: (2014)

SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Decreased expression of SPINT1-AS1 and SPINT1 mRNA might be independent unfavorable prognostic indicators in esophageal squamous cell carcinoma
por: Shen, Fang-Fang, et al.
Publicado: (2019)

High expression of MAGE-A9 is associated with unfavorable survival in esophageal squamous cell carcinoma
por: Qi, Yu, et al.
Publicado: (2017)

Elevated Preoperative NMPR Predicts an Unfavorable Chance of Survival in Resectable Esophageal Squamous Cell Carcinoma
por: Peng, Meng-Ying, et al.
Publicado: (2022)

Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer
por: Boldrin, Elisa, et al.
Publicado: (2019)

Expression of ERCC1, TYMS, TUBB3, RRM1 and TOP2A in patients with esophageal squamous cell carcinoma: A hierarchical clustering analysis
por: YU, YONGKANG, et al.
Publicado: (2014)

Germline ERCC excision repair 6 like 2 ( ERCC6L2 ) mutations lead to impaired erythropoiesis and reshaping of the bone marrow microenvironment
por: Armes, Hannah, et al.
Publicado: (2022)

Expression and Genetic Polymorphisms of ERCC1 in Chinese Han Patients with Oral Squamous Cell Carcinoma
por: Wang, Chaokui, et al.
Publicado: (2020)

Overexpression of Periostin and Lumican in Esophageal Squamous Cell Carcinoma
por: Kashyap, Manoj Kumar, et al.
Publicado: (2010)

Elucidating the role of excision repair cross-complement group 1 in oral epithelial dysplasia and early invasive squamous cell carcinoma: An immunohistochemical study
por: Kulkarni, Spoorti, et al.
Publicado: (2020)

X-Ray Repair Cross Complementing Protein 1 in Base Excision Repair
por: Hanssen-Bauer, Audun, et al.
Publicado: (2012)

Metabolic remodeling by TIGAR overexpression is a therapeutic target in esophageal squamous-cell carcinoma
por: Chu, Jiahui, et al.
Publicado: (2020)

HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP
por: Suh, Dong Hoon, et al.
Publicado: (2023)

Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma
por: Kreycy, Nele, et al.
Publicado: (2017)

Overexpression of suppressor of zest 12 is associated with cervical node metastasis and unfavorable prognosis in tongue squamous cell carcinoma
por: Hu, Huijun, et al.
Publicado: (2017)

Overexpression of TAF1L Promotes Cell Proliferation, Migration and Invasion in Esophageal Squamous Cell Carcinoma
por: Zhong, Shan, et al.
Publicado: (2019)

XPF–ERCC1: Linchpin of DNA crosslink repair
por: McHugh, Peter J.
Publicado: (2020)

MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
por: Abboud, H.S., et al.
Publicado: (2021)

Deletion of the Nucleotide Excision Repair Gene Ercc1 Reduces Immunoglobulin Class Switching and Alters Mutations Near Switch Recombination Junctions
por: Schrader, Carol E., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_g89a1cvhqk7cjbbqlf77dkmtbj